Alpha-Adrenergic Blockers: Examples and Classification
Alpha-adrenergic blockers include selective alpha-1 antagonists (doxazosin, prazosin, terazosin, tamsulosin, alfuzosin), nonselective alpha antagonists (phentolamine, phenoxybenzamine), and combined alpha-beta blockers (labetalol, carvedilol).
Selective Alpha-1 Adrenergic Blockers
These agents selectively block postsynaptic alpha-1 receptors and are commonly used for hypertension and benign prostatic hyperplasia:
- Doxazosin – Long-acting alpha-1 blocker used for hypertension (1-16 mg daily) and BPH 1, 2
- Prazosin – Shorter-acting agent requiring 2-3 times daily dosing (2-20 mg/day) 1, 3
- Terazosin – Long-acting formulation dosed 1-2 times daily (1-20 mg/day) 1, 3
- Tamsulosin – Uroselective alpha-1 blocker primarily used for BPH, with lower orthostatic hypotension risk but higher ejaculatory dysfunction rates 2, 3
- Alfuzosin – Used for BPH with potentially lower orthostatic hypotension risk compared to doxazosin or terazosin 2, 3
These selective agents cause less cardiovascular side effects than nonselective blockers because they spare presynaptic alpha-2 receptors, preventing accelerated norepinephrine release 4.
Nonselective Alpha Adrenergic Blockers
These agents block both alpha-1 and alpha-2 receptors and are reserved for specific indications:
- Phentolamine – Nonselective alpha antagonist used IV (5 mg bolus) for hypertensive emergencies induced by catecholamine excess, including pheochromocytoma, cocaine toxicity, amphetamine overdose, and clonidine withdrawal 1
- Phenoxybenzamine – Noncompetitive, nonselective alpha-1 and alpha-2 blocker used for preoperative management of pheochromocytoma, typically started 7-14 days before surgery with gradual dose titration 1, 3
These nonselective agents are now restricted primarily to alpha-adrenergic crisis management and pheochromocytoma due to their extensive adverse effect profile 5.
Combined Alpha-Beta Adrenergic Blockers
These agents provide both alpha-1 and beta-adrenergic blockade in a single molecule:
- Labetalol – Combined alpha-1 and nonselective beta blocker used IV for hypertensive emergencies (0.3-1.0 mg/kg bolus up to 20 mg, or 0.4-1.0 mg/kg/h infusion) and orally for chronic hypertension (200-800 mg twice daily) 1
- Carvedilol – Combined alpha and beta blocker preferred in heart failure with reduced ejection fraction (12.5-50 mg twice daily for immediate release) 1, 6
Labetalol is particularly useful in hyperadrenergic syndromes but is contraindicated in reactive airways disease, chronic obstructive pulmonary disease, and decompensated heart failure 1.
Key Clinical Distinctions
Orthostatic hypotension occurs most frequently with nonselective agents (doxazosin, terazosin, phenoxybenzamine) and requires dose titration starting at bedtime 2, 5. Tamsulosin demonstrates lower orthostatic risk but higher rates of ejaculatory dysfunction 2.
Esmolol is a beta-1 selective blocker (not an alpha blocker) sometimes confused in this category, used for acute rate control in tachyarrhythmias 1.
Alpha-1 blockers should not be assumed to provide optimal hypertension management; separate antihypertensive therapy is often required 2. In patients with cardiac risk factors, doxazosin monotherapy carries higher congestive heart failure incidence than other antihypertensives 2.